Top compounds associated with response to ERCC2


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0004
mRNA GSK690693 GDSC1000 pan-cancer AAC -0.11 0.0004
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC 0.12 0.0004
mRNA Nilotinib GDSC1000 pan-cancer AAC 0.13 0.0004
mRNA PF-562271 GDSC1000 pan-cancer AAC 0.12 0.0005
mRNA PD 153035 CTRPv2 pan-cancer AAC -0.16 0.0006
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.19 0.0006
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA BX-795 GDSC1000 pan-cancer AAC 0.11 0.0008
Download CSV